Development Level

Tbio 8 | 11,445
Tchem 1 | 1,598

IMPC Phenotype

increased circulating choleste... 2 | 66
abnormal heart morphology 1 | 162
abnormal tooth morphology 1 | 24
cardiovascular system phenotyp... 1 | 36
decreased cardiac muscle contr... 1 | 11
decreased circulating glucose ... 1 | 126
decreased circulating insulin ... 1 | 76
decreased circulating serum al... 1 | 82
decreased circulating sodium l... 1 | 22
decreased erythrocyte cell num... 1 | 62
decreased heart rate 1 | 18
decreased total body fat amoun... 1 | 207
decreased vertical activity 1 | 208
embryonic lethality prior to o... 1 | 239
enlarged heart 1 | 210
enlarged spleen 1 | 41
increased circulating LDL chol... 1 | 13
increased circulating alkaline... 1 | 122
increased circulating bilirubi... 1 | 16
increased circulating free fat... 1 | 20
increased circulating triglyce... 1 | 42
increased mean corpuscular hem... 1 | 36
increased total body fat amoun... 1 | 134
preweaning lethality, complete... 1 | 979
prolonged PQ interval 1 | 5
prolonged QT interval 1 | 38

Disease

Atherosclerosis 6 | 291
Coronary artery disease 6 | 268
Lipid metabolism disorder 5 | 114
Kidney disease 4 | 430
Proteinuria 4 | 144
diabetes mellitus 4 | 1,728
osteosarcoma 4 | 7,950
ovarian cancer 4 | 8,520
Amyloidosis 3 | 67
Anemia 3 | 365
Autosomal recessive predisposition 3 | 1,442
Carcinoma 3 | 11,493
Edema 3 | 81
Hepatomegaly 3 | 285
Kidney cancer 3 | 2,613
Splenomegaly 3 | 190
intraductal papillary-mucinous neoplasm (IPMN) 3 | 3,291
invasive ductal carcinoma 3 | 2,951
nephrosclerosis 3 | 333
oligodendroglioma 3 | 2,850
pancreatic ductal adenocarcinoma liver metastasis 3 | 1,962
psoriasis 3 | 6,694
3-methylglutaconic aciduria type 1 2 | 7
Adenocarcinoma 2 | 122
Alzheimer's disease 2 | 658
Arcus Senilis 2 | 11
Cancer 2 | 2,499
Cerebrovascular disease 2 | 238
Chemical and Drug Induced Liver Injury 2 | 195
Dementia 2 | 175
Drug Eruptions 2 | 18
Familial hyperlipidemia 2 | 6
Heart disease 2 | 306
High density lipoprotein decreased 2 | 10
Hypercholesterolemia, Autosomal Dominant, Type B 2 | 5
Hypercholesterolemia, Familial 2 | 23
Hyperlipoproteinemia Type II 2 | 12
Hyperlipoproteinemia Type IIa 2 | 11
Hypertension 2 | 396
Hypertensive disease 2 | 292
Hypertriglyceridemia result 2 | 37
Hypoalphalipoproteinemias 2 | 10
Kidney Failure 2 | 111
Liver disease 2 | 237
Lung Neoplasms 2 | 232
Megaloblastic Anemia 1 2 | 2
Megaloblastic anemia 2 | 18
Megaloblastic anemia due to inborn errors of metabolism 2 | 2
Obesity 2 | 678
Vitamin B12 deficiency 2 | 20
adrenocortical carcinoma 2 | 1,428
ependymoma 2 | 4,679
group 3 medulloblastoma 2 | 4,104
intraductal papillary-mucinous adenoma (IPMA) 2 | 2,955
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,989
malignant mesothelioma 2 | 3,232
medulloblastoma, large-cell 2 | 6,241
subependymal giant cell astrocytoma 2 | 2,287
ulcerative colitis 2 | 1,819
Acute Lung Injury 1 | 22
Adenocarcinoma of lung (disorder) 1 | 60
Alcohol abuse 1 | 50
Behcet Syndrome 1 | 21
Behcet's syndrome 1 | 50
Blepharitis 1 | 23
Carotid Artery Diseases 1 | 11
Carotid stenosis 1 | 5
Cellulitis of eyelid 1 | 17
Chromosome 2q37 deletion syndrome 1 | 4
Confusion 1 | 21
Delirium 1 | 10
Diabetic Cardiomyopathies 1 | 10
Dyslipidemias 1 | 27
Emphysema 1 | 12
Fanconi-like syndrome 1 | 3
Hematuria 1 | 36
Hemiplegia and hemiparesis 1 | 38
Hepatolenticular Degeneration 1 | 24
Hyperglycemia 1 | 137
Hypesthesia 1 | 7
Kidney Failure, Chronic 1 | 46
Liver Neoplasms, Experimental 1 | 59
Long tract signs 1 | 3
Lysosomal storage disease 1 | 10
Macular Degeneration, Age-Related, 1 1 | 9
Malabsorption of vitamin B12 (cyanocobalamin) 1 | 2
Marijuana Abuse 1 | 31
Multiple, subcutaneous nodules 1 | 53
Neoplastic Processes 1 | 10
Neurofibrillary degeneration (morphologic abnormality) 1 | 9
Neurogenic Inflammation 1 | 12
Pathological accumulation of air in tissues 1 | 10
Phencyclidine abuse 1 | 6
Renal glomerular disease 1 | 12
Serum cholesterol raised 1 | 22
Steatohepatitis 1 | 44
Subcutaneous nodule 1 | 53
Syndromic X-linked intellectual disability Snyder type 1 | 21
Tangier disease 1 | 10
Vitamin B12 deficiency caused by intestinal malabsorption 1 | 2

Tissue

Blood and immune system 9 | 16,909
Digestive Tract 9 | 17,369
Endocrine System 9 | 18,159
Female tissues 9 | 17,400
Liver and Pancreas 9 | 16,750
Male tissues 9 | 17,142
Nervous System 9 | 16,725
Respiratory system 9 | 16,393
Skin and soft tissues 9 | 17,230
Urinary Tract 9 | 16,678
Cardiovascular System 7 | 15,192

Target Family

Non-IDG 9 | 12,091

GO Process

high-density lipoprotein parti... 9 | 9
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Vigilin HDLBP Tbio Non-IDG -2.01228 106.9 233
Scavenger receptor class B member 1 SCARB1 Tchem Non-IDG -2.93920 915.7 378
Protein amnionless AMN Tbio Non-IDG -1.36104 18.1 35
Apolipoprotein C-II APOC2 Tbio Non-IDG -2.51086 342.7 22
Apolipoprotein A-II APOA2 Tbio Non-IDG -2.81123 595.2 420
Apolipoprotein A-I APOA1 Tbio Non-IDG -3.62534 3592.8 1151
Apolipoprotein E APOE Tbio Non-IDG -4.20176 15904.9 976
Cubilin CUBN Tbio Non-IDG -2.18842 161.0 78
Apolipoprotein M APOM Tbio Non-IDG -2.36916 258.4 374